C
블루엠텍
439580KOSDAQ45.0 / 100
Reference Date: 2026-10-23
Financial Score17.5 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 14.5% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
BlueEmtek operates pharmaceutical distribution platforms such as BluePharmKorea and KoolPharm, selling specialized medications to hospitals and pharmacies. The company also provides the online order management system 'BOS' and cold chain logistics solutions to enhance pharmaceutical distribution efficiency, and operates a medical staffing platform called BlueDoc.
Number of Employees
98people
Average Salary
48.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
1.67Industry Average 1.202.5Point
Higher than industry avg (caution)
ROE
-9.81Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
20.30Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲28.3% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼270.9% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -10.1% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (19%, downtrend)
Current 2,215Won52-week high 5,34052-week low 1,466
1-month return1.0Point
1m -14.48% (falling)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
7 totalPositive 1Neutral 6Negative 0
- Neutral신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득 (제3회차)2026-10-15
- Neutral주식등의대량보유상황보고서(일반)2026-10-14
- Neutral주식등의대량보유상황보고서(일반)2026-10-14
- Positive최대주주변경을수반하는주식양수도계약체결2026-10-08
- Neutral주주명부폐쇄기간또는기준일설정2026-10-08